| 2026 |
| 03/06 | 9,577 | 9,646 | 9,492 | 9,586 | -1.45% | 1,997,200 | 16兆954億 | +1.77% |
| 03/05 | 9,971 | 10,090 | 9,676 | 9,727 | -0.31% | 2,145,600 | 16兆3321億 | +3.78% |
| 03/04 | 9,750 | 9,822 | 9,603 | 9,757 | -1.16% | 2,583,900 | 16兆3825億 | +4.58% |
| 03/03 | 9,939 | 10,030 | 9,792 | 9,872 | -2.69% | 1,849,000 | 16兆5756億 | +6.3% |
| 03/02 | 10,390 | 10,520 | 10,110 | 10,145 | -2.97% | 2,092,300 | 17兆340億 | +9.76% |
| 02/27 | 10,410 | 10,570 | 10,375 | 10,455 | +1.55% | 2,840,500 | 17兆5545億 | +13.98% |
| 02/26 | 10,290 | 10,400 | 10,185 | 10,295 | -0.53% | 2,462,300 | 17兆2858億 | +13.29% |
| 02/25 | 10,700 | 10,700 | 10,205 | 10,350 | +2.48% | 2,905,200 | 17兆3782億 | +14.94% |
| 02/24 | 10,220 | 10,220 | 9,902 | 10,100 | +1.71% | 3,178,500 | 16兆9584億 | +13.23% |
| 02/20 | 9,675 | 9,955 | 9,653 | 9,930 | +3.49% | 3,008,100 | 16兆6730億 | +12.25% |
| 02/19 | 9,348 | 9,627 | 9,337 | 9,595 | +2.07% | 2,179,500 | 16兆1105億 | +9.12% |
| 02/18 | 9,219 | 9,400 | 9,219 | 9,400 | +2.51% | 1,435,000 | 15兆7831億 | +7.43% |
| 02/17 | 9,212 | 9,243 | 9,131 | 9,170 | -1.21% | 2,114,200 | 15兆3969億 | +5.26% |
| 02/16 | 9,300 | 9,319 | 9,200 | 9,282 | +0.02% | 1,526,100 | 15兆5850億 | +6.91% |
| 02/13 | 9,101 | 9,342 | 9,038 | 9,280 | +0.87% | 3,429,500 | 15兆5816億 | +7.28% |
| 02/12 | 9,227 | 9,310 | 9,156 | 9,200 | +1.97% | 2,381,100 | 15兆4473億 | +6.79% |
| 02/10 | 9,104 | 9,175 | 9,003 | 9,022 | -1.14% | 2,125,100 | 15兆1484億 | +5.16% |
| 02/09 | 9,397 | 9,460 | 9,012 | 9,126 | +6.02% | 3,667,500 | 15兆3230億 | +6.62% |
| 02/06 | 8,850 | 8,900 | 8,608 | 8,608 | -5.67% | 3,777,900 | 14兆4533億 | +0.99% |
| 02/05 | 9,152 | 9,441 | 8,983 | 9,125 | +4.86% | 5,012,600 | 15兆3214億 | +7.21% |
| 02/04 | 8,700 | 8,790 | 8,642 | 8,702 | -1.46% | 2,410,200 | 14兆6111億 | +2.58% |
| 02/03 | 8,802 | 8,985 | 8,745 | 8,831 | +0.33% | 2,561,400 | 14兆8277億 | +4.29% |
| 02/02 | 8,951 | 9,033 | 8,802 | 8,802 | +0.01% | 2,649,300 | 14兆7790億 | +4.23% |
| 01/30 | 8,759 | 8,982 | 8,592 | 8,801 | +5.92% | 4,759,000 | 14兆7773億 | +4.44% |
| 01/29 | (IR情報)17:00 剰余金の配当に関するお知らせ |
| 01/29 | (IR情報)17:00 2025年12月期連結決算〔IFRS〕補足資料 |
| 01/29 | (IR情報)17:00 株式報酬制度の改定に関するお知らせ |
| 01/29 | (IR情報)17:00 2025年12月期決算短信〔IFRS〕(連結) |
| 01/29 | (IR情報)15:00 エフ・ホフマン・ラ・ロシュの2025年度決算発表について |
| 01/29 | 8,339 | 8,430 | 8,275 | 8,309 | -1.63% | 2,367,500 | 13兆9512億 | -1.14% |
| 01/28 | 8,451 | 8,560 | 8,365 | 8,447 | -2.26% | 1,817,200 | 14兆1830億 | +0.5% |
| 01/27 | 8,662 | 8,686 | 8,515 | 8,642 | -0.59% | 2,097,900 | 14兆5104億 | +2.95% |
| 01/26 | 8,454 | 8,693 | 8,450 | 8,693 | -0.69% | 2,019,500 | 14兆5960億 | +3.78% |
| 01/23 | 8,651 | 8,796 | 8,609 | 8,753 | +4.2% | 3,173,700 | 14兆6967億 | +4.71% |
| 01/22 | 8,465 | 8,470 | 8,297 | 8,400 | +1.02% | 1,990,700 | 14兆1040億 | +0.61% |
| 01/21 | 8,202 | 8,315 | 8,171 | 8,315 | +0.87% | 1,755,300 | 13兆9613億 | -0.48% |
| 01/20 | 8,250 | 8,296 | 8,182 | 8,243 | +0.18% | 1,557,500 | 13兆8404億 | -1.36% |
| 01/19 | 8,245 | 8,307 | 8,168 | 8,228 | -0.29% | 1,506,200 | 13兆8152億 | -1.51% |
| 01/16 | 8,348 | 8,360 | 8,204 | 8,252 | -3.98% | 2,142,100 | 13兆8555億 | -1.2% |
| 01/15 | 8,618 | 8,765 | 8,552 | 8,594 | +0.77% | 2,264,500 | 14兆4298億 | +2.91% |
| 01/14 | 8,499 | 8,616 | 8,437 | 8,528 | +1.08% | 1,951,300 | 14兆3190億 | +2.3% |
| 01/13 | 8,500 | 8,607 | 8,390 | 8,437 | +0.19% | 2,181,100 | 14兆1662億 | +1.24% |
| 01/09 | 8,450 | 8,495 | 8,349 | 8,421 | -0.87% | 2,208,400 | 14兆1393億 | +1.15% |
| 01/08 | 8,536 | 8,607 | 8,376 | 8,495 | +1.13% | 2,677,900 | 14兆2635億 | +2.18% |
| 01/07 | 8,325 | 8,437 | 8,310 | 8,400 | +1.17% | 1,718,900 | 14兆1040億 | +1.24% |
| 01/06 | 8,430 | 8,500 | 8,238 | 8,303 | -2.5% | 2,673,700 | 13兆9412億 | +0.08% |
| 01/05 | 8,350 | 8,527 | 8,328 | 8,516 | +3.31% | 2,063,700 | 14兆2988億 | +2.59% |
| 12/30 | (IR情報)10:00 (開示事項の経過)レナリスファーマ株式会社の完全子会社化及び吸収合併完了に関するお知らせ |
| 2025 |
| 12/30 | 8,298 | 8,328 | 8,191 | 8,243 | -0.75% | 1,860,500 | 13兆8404億 | -0.72% |
| 12/29 | 8,290 | 8,312 | 8,218 | 8,305 | -1.25% | 1,387,600 | 13兆9445億 | -0.04% |
| 12/26 | 8,340 | 8,447 | 8,340 | 8,410 | +0.97% | 1,250,200 | 14兆1208億 | +1.2% |
| 12/25 | 8,305 | 8,333 | 8,250 | 8,329 | +0.76% | 763,400 | 13兆9848億 | +0.29% |
| 12/24 | 8,449 | 8,472 | 8,266 | 8,266 | -0.89% | 2,031,300 | 13兆8790億 | -0.39% |
| 12/23 | 8,318 | 8,402 | 8,282 | 8,340 | +0.94% | 1,708,500 | 14兆33億 | +0.48% |
| 12/22 | 8,300 | 8,356 | 8,241 | 8,262 | -0.35% | 971,100 | 13兆8723億 | -0.53% |
| 12/19 | 8,295 | 8,414 | 8,190 | 8,291 | +1.22% | 2,666,300 | 13兆9210億 | -0.11% |
| 12/18 | (IR情報)22:00 経口GLP-1受容体作動薬オルホルグリプロンに関するEli Lilly社の発表について |
| 12/18 | 8,101 | 8,311 | 8,100 | 8,191 | +0.17% | 1,445,900 | 13兆7531億 | -1.22% |
| 12/17 | 8,119 | 8,233 | 8,065 | 8,177 | -1.11% | 2,188,100 | 13兆7296億 | -1.23% |
| 12/16 | 8,500 | 8,500 | 8,269 | 8,269 | -2.88% | 1,952,200 | 13兆8841億 | +0.21% |
| 12/15 | 8,575 | 8,690 | 8,514 | 8,514 | -0.34% | 1,661,400 | 14兆2954億 | +3.69% |
| 12/12 | 8,477 | 8,629 | 8,376 | 8,543 | +1.99% | 3,564,700 | 14兆3441億 | +4.58% |
| 12/11 | 8,395 | 8,512 | 8,277 | 8,376 | +2.77% | 2,615,700 | 14兆637億 | +3.33% |
| 12/10 | 8,153 | 8,194 | 8,057 | 8,150 | -0.45% | 1,703,700 | 13兆6843億 | +1.23% |
| 12/09 | 8,224 | 8,264 | 8,111 | 8,187 | -0.45% | 1,477,700 | 13兆7464億 | +2.3% |
| 12/08 | 8,260 | 8,274 | 8,188 | 8,224 | -0.11% | 1,338,800 | 13兆8085億 | +3.36% |
| 12/05 | 8,390 | 8,393 | 8,210 | 8,233 | -2.82% | 1,349,900 | 13兆8236億 | +4.2% |
| 12/04 | 8,303 | 8,492 | 8,223 | 8,472 | +3.15% | 2,349,500 | 14兆2249億 | +8.01% |
| 12/03 | 8,098 | 8,264 | 8,080 | 8,213 | +0.77% | 1,876,400 | 13兆7901億 | +5.55% |
| 12/02 | 8,155 | 8,168 | 8,084 | 8,150 | +0.97% | 1,931,600 | 13兆6843億 | +5.52% |
| 12/01 | 8,269 | 8,311 | 8,040 | 8,072 | -3.61% | 2,517,200 | 13兆5533億 | +5.17% |
| 11/28 | 8,330 | 8,374 | 8,250 | 8,374 | -0.62% | 1,768,300 | 14兆604億 | +9.64% |
| 11/27 | 8,447 | 8,549 | 8,419 | 8,426 | -1.61% | 1,827,000 | 14兆1477億 | +10.99% |
| 11/26 | 8,377 | 8,612 | 8,309 | 8,564 | +2.46% | 2,217,900 | 14兆3794億 | +13.55% |
| 11/25 | 8,433 | 8,435 | 8,239 | 8,358 | -0.12% | 2,647,200 | 14兆335億 | +11.71% |
| 11/21 | 8,320 | 8,435 | 8,284 | 8,368 | +1.09% | 4,143,500 | 14兆503億 | +12.73% |
| 11/20 | 8,050 | 8,392 | 8,023 | 8,278 | +1.43% | 2,470,900 | 13兆8992億 | +12.34% |
| 11/19 | 8,294 | 8,339 | 8,138 | 8,161 | -1.67% | 3,014,700 | 13兆7027億 | +11.5% |
| 11/18 | (IR情報)17:30 完全子会社(レナリスファーマ株式会社)の吸収合併に関するお知らせ |
| 11/18 | 8,336 | 8,436 | 8,291 | 8,300 | -2.39% | 2,437,400 | 13兆9361億 | +14.12% |
| 11/17 | 8,263 | 8,574 | 8,230 | 8,503 | +4.81% | 3,647,400 | 14兆2770億 | +17.44% |
| 11/14 | 8,100 | 8,271 | 8,003 | 8,113 | +0.25% | 4,200,200 | 13兆6221億 | +12.77% |
| 11/13 | 8,000 | 8,211 | 7,952 | 8,093 | +3.1% | 2,956,300 | 13兆5886億 | +13.06% |
| 11/12 | 7,821 | 7,884 | 7,684 | 7,850 | +4.37% | 3,412,400 | 13兆1806億 | +10.21% |
| 11/11 | 7,377 | 7,553 | 7,352 | 7,521 | +3.91% | 2,352,300 | 12兆6281億 | +5.96% |
| 11/10 | 7,242 | 7,339 | 7,204 | 7,238 | -3.08% | 2,249,700 | 12兆1530億 | +2.27% |
| 11/07 | 7,100 | 7,478 | 7,038 | 7,468 | +7.44% | 5,366,900 | 12兆5392億 | +5.78% |
| 11/06 | 7,000 | 7,110 | 6,946 | 6,951 | -0.77% | 1,967,400 | 11兆6711億 | -1.11% |
| 11/05 | 7,048 | 7,113 | 6,848 | 7,005 | +0.82% | 3,424,800 | 11兆7617億 | -0.06% |
| 11/04 | 7,000 | 7,020 | 6,845 | 6,948 | -1.43% | 2,839,100 | 11兆6660億 | -0.49% |
| 10/31 | 6,891 | 7,059 | 6,870 | 7,049 | +3.54% | 3,999,800 | 11兆8356億 | +1.35% |
| 10/30 | 6,771 | 6,819 | 6,691 | 6,808 | -0.07% | 2,432,600 | 11兆4310億 | -1.86% |
| 10/29 | 6,920 | 6,975 | 6,726 | 6,813 | -1.16% | 2,351,500 | 11兆4394億 | -1.77% |
| 10/28 | 6,887 | 6,922 | 6,804 | 6,893 | +1.56% | 2,400,600 | 11兆5737億 | -0.55% |
| 10/27 | 6,873 | 6,938 | 6,781 | 6,787 | -2.13% | 4,176,500 | 11兆3957億 | -2.04% |
| 10/24 | (IR情報)17:00 レナリスファーマ株式会社の完全子会社化に関するお知らせ |
| 10/24 | (IR情報)17:00 2025年12月期第3四半期連結決算〔IFRS〕補足資料 |
| 10/24 | (IR情報)17:00 2025年12月期第3四半期決算短信〔IFRS〕(連結) |
| 10/24 | 7,030 | 7,046 | 6,924 | 6,935 | -3.06% | 3,047,800 | 11兆6442億 | +0.12% |
| 10/23 | (IR情報)14:00 エフ・ホフマン・ラ・ロシュの2025年第3四半期の販売実績について |
| 10/23 | 7,178 | 7,296 | 7,122 | 7,154 | -1.02% | 2,382,500 | 12兆119億 | +3.4% |
| 10/22 | 7,204 | 7,303 | 7,180 | 7,228 | +0.98% | 2,191,700 | 12兆1362億 | +4.72% |
| 10/21 | 7,120 | 7,225 | 7,092 | 7,158 | +1.37% | 2,367,100 | 12兆186億 | +4.03% |
| 10/20 | 6,981 | 7,071 | 6,920 | 7,061 | +2.62% | 2,440,600 | 11兆8558億 | +2.93% |
| 10/20 | (IR情報)8:30 中外製薬とRani Therapeutics、RaniPill技術を用いた経口製剤の開発および商業化に関するライセンス契約を締結 |
| 10/17 | 6,903 | 6,934 | 6,810 | 6,881 | -2.26% | 2,557,200 | 11兆5535億 | +0.54% |
| 10/16 | 7,069 | 7,080 | 6,978 | 7,040 | +0.21% | 2,012,200 | 11兆8205億 | +2.94% |
| 10/15 | 6,960 | 7,060 | 6,917 | 7,025 | +0.36% | 2,124,700 | 11兆7953億 | +2.95% |
| 10/14 | 7,104 | 7,227 | 6,975 | 7,000 | -6.4% | 4,266,800 | 11兆7534億 | +2.82% |
| 10/10 | 7,426 | 7,499 | 7,208 | 7,479 | +1.71% | 3,636,000 | 12兆5576億 | +10.13% |
| 10/10 | (空売り報告)JPM Securities Japan Co Ltd. 8,113,195株(0.48%)-0.05%義務消失 |
| 10/09 | 7,279 | 7,373 | 7,272 | 7,353 | +2.08% | 2,309,000 | 12兆3461億 | +8.93% |
| 10/08 | 7,230 | 7,279 | 7,105 | 7,203 | -0.21% | 2,431,600 | 12兆942億 | +7.25% |
| 10/07 | 7,340 | 7,465 | 7,218 | 7,218 | -0.29% | 3,962,400 | 12兆1194億 | +7.91% |